Stockscreener 앱 받기
18.27
5.67%
0.98
시간 외 거래:
18.49
0.22
+1.20%
전일 마감가:
$17.29
열려 있는:
$17.4
하루 거래량:
160.54K
Relative Volume:
0.90
시가총액:
$1.12B
수익:
-
순이익/손실:
$-46.13M
주가수익비율:
-22.49
EPS:
-0.8123
순현금흐름:
$-34.10M
1주 성능:
+7.28%
1개월 성능:
+13.76%
6개월 성능:
+3.63%
1년 성능:
+166.72%
1일 변동 폭
$17.40
$18.40
1주일 범위
$16.40
$18.40
52주 변동 폭
$6.595
$25.00
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
PLSE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
18.27 | 1.12B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
478.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
199.88 | 57.39B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
93.31 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
214.08 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.79 | 15.89B | 3.90B | 392.30M | 288.10M | 1.95 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-07-27 | 개시 | Stephens | Overweight |
| 2021-03-11 | 개시 | Maxim Group | Buy |
| 2021-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
Trading (PLSE) With Integrated Risk Controls - news.stocktradersdaily.com
Vanguard Group Inc. Purchases 150,506 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Corebridge Financial Inc. Cuts Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
20,000 Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) Bought by Norges Bank - Defense World
KLP Kapitalforvaltning AS Buys Shares of 2,500 Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences: Some Key Questions Remain Unanswered - Seeking Alpha
Pulse Biosciences at Needham Conference: Strategic Growth and Market Expansion - Investing.com UK
Pulse Biosciences: Interesting Product, But No Revenue Stream (NASDAQ:PLSE) - Seeking Alpha
When (PLSE) Moves Investors should Listen - news.stocktradersdaily.com
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire
Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering - Business Wire
Pulse Biosciences (NASDAQ:PLSE) Upgraded to Sell at StockNews.com - Defense World
PULSE BIOSCIENCES, INC. SEC 10-K Report - TradingView
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Call Transcript - MSN
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up – What’s Next? - Defense World
Pulse Biosciences Insiders Placed Bullish Bets Worth US$2.79m - simplywall.st
Pulse Biosciences Earnings Call: Progress Amid Challenges - TipRanks
Pulse Biosciences Inc Reports Q4 2024 GAAP Net Loss of $19.4 Mil - GuruFocus
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results - TradingView
Charles Schwab Investment Management Inc. Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc (PLSE) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs - Yahoo Finance
Pulse Biosciences Inc (PLSE) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs By GuruFocus - Investing.com Canada
Earnings call transcript: Pulse Biosciences Q4 2024 misses EPS, stock rises - Investing.com Australia
Pulse Biosciences Inc. Reports 2024 Financial Results - TipRanks
Earnings call transcript: Pulse Biosciences Q4 2024 misses EPS, stock rises By Investing.com - Investing.com South Africa
Bank of New York Mellon Corp Has $676,000 Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences reports wider Q4 loss, shares dip By Investing.com - Investing.com South Africa
Pulse Biosciences reports wider Q4 loss, shares dip - Investing.com Australia
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results - Business Wire
Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference - BioSpace
Breakthrough nsPFA Technology Updates Coming at Major Healthcare Conference - Stock Titan
AlphaQuest LLC Lowers Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000 - Business Wire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors With Losses to Secure Counsel Before Important April 18 Deadline in Securities Class Action – PLSE - Business Wire
(PLSE) Trading Advice - Stock Traders Daily
Oppenheimer & Co. Inc. Acquires New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Oppenheimer & Co. Inc. Makes New $311,000 Investment in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Armenian Reporter
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025 - Bluefield Daily Telegraph
When Will Pulse Biosciences Report Q4 Earnings? Key Date for nsPFA Technology Leader - StockTitan
Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences at TD Cowen Conference: nsPFA Technology Focus By Investing.com - Investing.com Canada
New York State Common Retirement Fund Sells 3,600 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) Trading Signals - news.stocktradersdaily.com
Commit To Purchase Pulse Biosciences At $10, Earn 12.9% Annualized Using Options - Nasdaq
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Joplin Globe
MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.56%
자본화:
|
볼륨(24시간):